J. Sierra-Sánchez

Medication Reconciliation in Oncological Patients: A Randomized Clinical Trial.

J. M. Baena-Cañada, T. Vega, J. Sierra-Sánchez, 2016, Journal of managed care & specialty pharmacy.

Peptic disease: a confounding factor for proton pump inhibitor-clopidogrel interaction?

J. Sierra-Sánchez, E. A. Alegre-del Rey, R. Castaño-Lara, 2010, The American journal of cardiology.

▼Tiotropium for chronic obstructive pulmonary disease

J. Sierra-Sánchez, E. A. Alegre-del Rey, Isidoro Cobo, 2003, The New England journal of medicine.

Machine-learning-derived predictive score for early estimation of COVID-19 mortality risk in hospitalized patients

Sonia Tarazona, D. Palací‐López, M. Climente-Martí, 2022, PloS one.

Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain

Z. Špacírová, A. Olry de Labry Lima, M. Aranzana, 2021, Breast.

A randomised controlled trial on the efficacy of a multidisciplinary health care team on morbidity and mortality of elderly patients attending the Emergency Department. Study design and preliminary results.

J. Arévalo-Serrano, J. Sierra-Sánchez, B. Calderón-Hernanz, 2016, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19.

J. Sierra-Sánchez, MD Gil-Sierra, S. Fénix-Caballero, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives

F. Otero-Espinar, A. Fernández-Ferreiro, E. Yebra-Pimentel, 2020, Pharmaceutics.

Degree of prescriber’s knowledge about variability in biological drugs “innovators” in manufacturing process

R. Gázquez-Pérez, J. Sierra-Sánchez, L. Jiménez-Pichardo, 2018, European Journal of Clinical Pharmacology.

Factors associated with mortality in patients hospitalized for COVID-19 in Spain. Data from the RERFAR registry.

J. Sierra-Sánchez, Emilio García-Cabrera, Antonio Olry de Labry-Lima, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Discrepancies requiring clarification in cancer patients: a risk predictive model

J. Sierra-Sánchez, M. J. Martínez-Bautista, J. B. Cañada, 2012 .